Showing results (41-50 of 62) with videos related to
Sort By:
Pageof 7
Thrombosis and Haemostasis|August 26, 1998
Factor Xa cleavage of tissue factor pathway inhibitor is associated with loss of anticoagulant activityI Salemink, J Franssen, G M Willems, et al.The Journal of Clinical Investigation|July 15, 1996
Renal expression of tissue factor pathway inhibitor and evidence for a role in crescentic glomerulonephritis in rabbitsJ H Erlich, J Apostolopoulos, T C Wun, et al.Thrombosis and Haemostasis|July 6, 1992
Clearance of recombinant tissue factor pathway inhibitor (TFPI) in rabbitsM O Palmier, L J Hall, C M Reisch, et al.Journal of Molecular Biology|March 5, 1990
Crystallization of a chymotrypsin inhibitor from Erythrina caffra seedsH S Shieh, N K Leimgruber, M O Palmier, et al.The Journal of Surgical Research|January 1, 1996
Tissue factor and its inhibition at the human microvascular anastomosisG A Dumanian, B V Heil, R K Khouri, et al.Surgery|March 1, 1996
Prevention of spinal cord injury after transient aortic clamping with tissue factor pathway inhibitorB Koudsi, C D Yu, E W Ferguson, et al.The Journal of Biological Chemistry|May 5, 1992
Internalization of the urokinase-plasminogen activator inhibitor type-1 complex is mediated by the urokinase receptorD Olson, J Pöllänen, G Høyer-Hansen, et al.Laboratory Investigation; a Journal of Technical Methods and Pathology|July 1, 1989
Plasminogen activator inhibitor types 1 and 2 in human trophoblasts. PAI-1 is an immunocytochemical marker of invading trophoblastsR F Feinberg, L C Kao, J E Haimowitz, et al.The Journal of Biological Chemistry|September 25, 1992
Separation and characterization of nonphosphorylated and serine-phosphorylated urokinase. Catalytic properties and sensitivity to plasminogen activator inhibitor type 1P Franco, M R Mastronicola, D De Cesare, et al.Circulation|August 1, 1991
Prevention of arterial reocclusion after thrombolysis with recombinant lipoprotein-associated coagulation inhibitorE J Haskel, S R Torr, K C Day, et al.Pageof 7